Brett Haumann Insider Profile
4 Followers
Brett Haumann, former CMO at Theravance Biopharma, holds 242.50K shares in Theravance Biopharma (Ticker: TBPH), holds 0.00 shares in Aimmune Therapeutics (Ticker: AIMT).
Brett Haumann's Trading History
| TBPHTheravance Biopharma | Feb 23, 2021 | ― | Uninformative Sell | 670.28K | $4.13M | |
| AIMTAimmune Therapeutics | Oct 14, 2020 | ― | Uninformative Sell | 459.30K | $0.00 |
You May Also Like
Brett Haumann insider profile FAQ
What is the percentage of profitable transactions made by Brett Haumann?
The percentage of profitable transactions made by Brett Haumann is 75%.
What is the average return per transaction made by Brett Haumann?
The average return per transaction made by Brett Haumann is 13.60%.
What stocks does Brett Haumann hold?
Brett Haumann holds: TBPH, AIMT stocks.
What was Brett Haumann’s latest transaction?
Brett Haumann’s latest transaction was an Uninformative Sell of $670.28K.
What was Brett Haumann's most profitable transaction?
Brett Haumann’s most profitable transaction was an Informative Sell of TBPH stock on August 24, 2020. The return on the trade was 48.50%.
What is Brett Haumann's role in Theravance Biopharma?
Brett Haumann's role in Theravance Biopharma is CMO.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.
TipRanks measures corporate insiders by the stock transactions they report to the SEC. See how TipRanks ranks experts and calculates performance.
